共 50 条
Reproductive late effects after hematopoietic stem cell transplant in pediatric, adolescent, and young adult cancer survivors
被引:1
|作者:
Appiah, Leslie C.
[1
,2
]
Moravek, Molly
[3
]
Hoefgen, Holly
[4
]
Rotz, Seth
[5
]
Childress, Krista
[6
]
Samis, Jill
[7
]
Benoit, Janie
[8
]
Rodriguez-Wallberg, Kenny
[9
]
Anazodo, Antoinette
[10
,11
]
机构:
[1] Univ Colorado, Dept Obstet & Gynecol, Div Acad Specialists Obstet & Gynecol, Sch Med, Denver, CO 80309 USA
[2] Childrens Hosp Colorado, Dept Pediat & Adolescent Gynecol, Denver, CO USA
[3] Univ Michigan Med, Dept Reprod Endocrinol & Infertil, Ann Arbor, MI USA
[4] Washington Univ St Louis, St Louis, MI USA
[5] Cleveland Clin, Dept Pediat Hematol Oncol & Bone Marrow Transplant, Cleveland, OH USA
[6] Primary Childrens Med Ctr, Dept Pediat & Adolescent Gynecol, Salt Lake City, UT USA
[7] Lurie Childrens Hosp, Dept Endocrinol, Chicago, IL USA
[8] Univ Montreal, Montreal, PQ, Canada
[9] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[10] Sydney Childrens Hosp, Kids Canc Ctr, Sydney, NSW, Australia
[11] Univ New South Wales, Sydney, NSW, Australia
关键词:
adolescent;
genital graft-versus-host disease;
gonadal insufficiency;
hematopoietic stem cell transplant;
hormone therapy;
pediatric;
radiation-induced uterine injury;
radiation-induced breast cancer;
reproductive late effects;
young adult (AYA) cancer;
BONE-MARROW-TRANSPLANTATION;
VERSUS-HOST-DISEASE;
TOTAL-BODY IRRADIATION;
PREMATURE OVARIAN FAILURE;
LONG-TERM SURVIVORS;
CONSENSUS DEVELOPMENT PROJECT;
HORMONE REPLACEMENT THERAPY;
CHILDHOOD-CANCER;
BREAST-CANCER;
FEMALE SURVIVORS;
D O I:
10.1002/pbc.30551
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Reproductive late effects after hematopoietic stem cell transplant can have a significant impact on cancer survivors' quality of life. Potential late effects include gonadal insufficiency, genital graft-versus-host disease, uterine injury, psychosexual dysfunction, and an increased risk of breast and cervical cancer in patients treated with total body irradiation. Despite guidelines, screening and treatment are not standardized among at-risk patients. Provider barriers include lack of knowledge of at-risk therapies and evidenced-based guidelines. Patient barriers include a reluctance to report symptoms and lack of awareness of treatment options. System barriers include inefficient implementation of screening tools and poor dissemination of guidelines to providers who serve as the medical home for survivors. This review guides the clinician in identifying and managing reproductive late effects after hematopoietic stem cell transplant to improve outcomes.
引用
收藏
页数:14
相关论文